Home > Boards > US OTC > Miscellaneous >

Halberd Corp. (HALB)

HALB RSS Feed
Add HALB Price Alert      Hide Sticky   Hide Intro
Moderator: solidgold, EHRjunkie, work-n-hard
Search This Board: 
Last Post: 1/24/2022 6:43:45 PM - Followers: 291 - Board type: Free - Posts Today: 0

 

 

HALBERD CORPORATION 


                                                                                   




https://halberdcorporation.com/

                
Email: support@halberdcorporation.com

HALB Security Details - https://www.otcmarkets.com/stock/HALB/security


Share Structure

Authorized Shares -    800,000,000 - a/o 01/19/2022

Shares Outstanding -  511,621,968 - a/o 01/19/2022

Float-  320,542,712 - a/o 10/31/2021


 

 Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.            

                                                                              
                                                                                      
HALB holds the exclusive rights to 3 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629



See YouTube video, https://youtu.be/BGdZqHH6oew, concerning Dr. Felder’s discussion of the scientific basis underlying Premier’s extracorporeal treatment process for fighting cancer and other diseases.
 

 

                                                                                                                                                                                                                                                         Halberd Corporation Pursues Extracorporeal Radio Frequency Treatment  Against Covid-19 | BioSpace
 

In plain English: HALB with its partners is developing an extra-corporeal (out of the body) treatment against Alzheimer's Disease and other virusses and  diseases. With the use of antibodies the diseases antigens are targeted. Using radiofrequency / laser technology antigens and cytokines are eradicated. All based on 3 granted patents and 16 (per 11/23/2021) provisional patent applications.
                                                                                                                                                                                                               

                                                                                                                                                                                                            

Halberd Corporation's Proprietary Technology for Alzheimer's Disease Enters Stage 4 of 7 Stage Process

Jackson Center, Pennsylvania--(Newsfile Corp. - June 21, 2021) - Halberd Corporation's (OTC Pink: HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases), eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Currently, there is no known effective treatment for Alzheimer's Disease which afflicts over 40 million people worldwide, equivalent to the combined population of the states of Florida and New York.

                                                                                            The seven (7) stages in Halberd's program are as follows:

  1.                                                                                                                                                                              1. Identifying target disease(s); (Done)
                                                                                                                                                                                 2. Creating patentable antibodies vs target disease(s); (Done)
                                                                                                                                                                                 3. Combining antibodies with metallic particles; (Done)
                                                                                                                                                                                 4. Eradicating the antibody-disease combination through radiofrequency waves, laser or other proprietary means; (In-process)
                                                                                                                                                                                 5. Conducting animal tests to establish the safety and efficacy; (Preliminary Planning)
                                                                                                                                                                                 6. Conducting human testing
                                                                                                                                                                                 7. Obtaining FDA Certification


     

Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"


https://www.accesswire.com/652434/Halberd-Corporations-Proprietary-Technology-for-Alzheimers-Disease-Enters-Stage-4-of-7-Stage-Process

                                                                                                                                                                                    https://cdn-dms-issuerservices.s3.amazonaws.com/7669/200000/1639955256/Halberd%20Testing%20Plans_5.png?AWSAccessKeyId=AKIAI422EKE3B4ZYHMSQ&Expires=1639955612&Signature=Td3JMiGOdHF5212jYA0ItERC4x0%3D


_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

 




 

 

 
 

 

 
 

 

 

 
HALB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#24990  Sticky Note This should help, links provided to verify accuracy: squidster 01/05/22 08:57:20 PM
#24953  Sticky Note $HALB Halberd Eradicates Another Inflammatory Cytokine, Interleukin-12, In Louied91 12/15/21 09:18:12 AM
#23294  Sticky Note What $HALB is working on: EHRjunkie 03/03/21 04:14:14 AM
#25009   no dip! look like? sundoctor 01/24/22 06:43:45 PM
#25008   Luv the tune… ‘Once again, dipping below 2. exisnet 01/23/22 07:08:30 PM
#25007   Once again, dipping below 2. My favorite tune. work-n-hard 01/19/22 05:39:48 PM
#25006   From the latest press release: EHRjunkie 01/17/22 08:23:54 AM
#25005   $HALB Halberd, Inc. (HALB) Reports Elimination of Target AskMuncher 01/17/22 02:36:23 AM
#25004   This was a very important step in this gkare 01/13/22 04:04:09 PM
#25003   Only TAU and GLUTAMATE to go to completely EHRjunkie 01/13/22 10:27:34 AM
#25002   Not so great this time with HALB, but work-n-hard 01/13/22 09:36:18 AM
#25001   $HALB Halberd, Inc. (HALB) Reports Elimination of Target Louied91 01/13/22 09:23:55 AM
#25000   It's that time again. :) work-n-hard 01/13/22 08:55:53 AM
#24999   solid news sundoctor 01/13/22 08:48:20 AM
#24998   No posts for Halberd for 5 days? mjt 01/12/22 08:01:03 PM
#24997   Come on back down sweetheart. :) work-n-hard 01/07/22 11:09:23 AM
#24996   $HALB Halberd Corporation Now an Official US Government Contractor AskMuncher 01/07/22 04:18:18 AM
#24995   Quite a feet, not diluting shareholder equity in squidster 01/06/22 10:10:08 PM
#24994   Agreed. That was then and things are much stocksmanjr 01/06/22 11:23:49 AM
#24993   Soaking TimeFades 01/06/22 09:37:13 AM
#24992   $HALB no dilution since 08/16/2021 (4.5 months) EHRjunkie 01/06/22 08:17:08 AM
#24991   For me the R&D-contract with Arizona State University EHRjunkie 01/06/22 07:53:06 AM
#24990   This should help, links provided to verify accuracy: squidster 01/05/22 08:57:20 PM
#24989   need more volume, the target in next few sundoctor 01/05/22 05:53:41 PM
#24988   Continuation or crash manana? TimeFades 01/05/22 05:37:18 PM
#24987   Willing to take the chance of watching it PennyPusher786 01/05/22 03:37:13 PM
#24986   Who would have gotten this just from reading trading.jeff 01/05/22 02:50:55 PM
#24985   This is a different company then it was gkare 01/05/22 02:26:09 PM
#24983   Asking here is part of that DD tbf RodneyRiotShield 01/05/22 02:07:45 PM
#24981   Best to do your own DD and not trading.jeff 01/05/22 11:29:22 AM
#24980   Has your assessment of Halberd changed here? RodneyRiotShield 01/05/22 11:17:37 AM
#24979   I want to buy shares but its hard RodneyRiotShield 01/05/22 11:16:14 AM
#24978   Let’s see what she’s got TimeFades 01/05/22 11:15:07 AM
#24977   Is retirement in my future! gkare 01/05/22 10:55:16 AM
#24976   Here she goes. work-n-hard 01/05/22 10:33:45 AM
#24975   Getting nutty now JMMatthews 01/05/22 10:32:32 AM
#24974   Wow nice dipnrip JMMatthews 01/05/22 10:29:47 AM
#24973   Doesn't mean federal contracts will fall into $HALB's trading.jeff 01/05/22 10:10:37 AM
#24972   Nice pop from 160's. work-n-hard 01/05/22 09:32:43 AM
#24971   Sweet news https://finance.yahoo.com/finance/news/halberd-corporation-now-offici JMMatthews 01/05/22 09:21:57 AM
#24970   $HALB Halberd Corporation Now an Official US Government Contractor Louied91 01/05/22 08:56:46 AM
#24969   $HALB 2022 is the breakthrough year for Halberd EHRjunkie 01/04/22 06:25:56 AM
#24968   Of course sundoctor 12/30/21 09:26:26 AM
#24967   Time for another reload??? work-n-hard 12/30/21 07:21:05 AM
#24966   https://ih.advfn.com/stock-market/USOTC/halberd-pk-HALB/trades squidster 12/27/21 07:29:07 PM
#24965   You sold 1.5M? sundoctor 12/27/21 07:06:16 PM
#24964   445K Buys / 1.6M Sells / 100K ? work-n-hard 12/27/21 04:33:22 PM
#24963   A few months ago Halberd issued a press EHRjunkie 12/24/21 04:51:30 AM
#24962   $HALB Halberd Moves Closer to Proving Its Patented AskMuncher 12/24/21 03:39:42 AM
#24961   Reload territory??? work-n-hard 12/23/21 02:08:37 PM
#24960   closer and closer,,, sundoctor 12/20/21 04:37:39 PM
#24959   $HALB Halberd Moves Closer to Proving Its Patented Louied91 12/20/21 09:15:35 AM
#24958   In a matter of weeks Halberd will reach EHRjunkie 12/20/21 08:43:41 AM
PostSubject
Consent Preferences